Table 1.
Characteristics of patients diagnosed with secondary malignant neoplasms after treatment on ALL-BFM trials 79 to 2000 included in targeted sequencing analyses in comparison to secondary malignant neoplasm patients not included.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.